title: [Identification of Mycobacterium tuberculosis and rifampin-resistant strains by gene-chips].
abstract: OBJECTIVE
  To evaluate the gene-chip detecting rifaman-resistance Mycobacterium tuberculosis applied in TB diagnosis and drug-resistant detection.
  
  
  METHODS
  Mycobacterium tuberculosis and rifaman-resistant strains among 35 rifaman-resistance isolated strains and 102 sputa specimens from TB patients, 27 sputa specimens from other patients were examined the gene-chips. Results obtained were compared with sputum examination, bacteriological culture and standard drug susceptibility test of Mycobacterium tuberculosis.
  
  
  RESULTS
  Thirty-five rifaman-resistance strains were detected by gene-chips and 33 were identified as rifaman-resistance strains and the concordance with the traditional drug susceptibility test of Mycobacterium tuberculosis was 94.29%. Twenty-seven sputa specimens from other patients were examined Mycobacterium tuberculosis by the gene-chips, 2 were positive, the detection specialty was 92.59%. Using three methods detecting Mycobacterium tuberculosis among 102 sputa specimens the positive rate respectively was, sputum examination 35.29% (36/102), bacteriological culture 28.43% (29/102), gene-chip 77.45% (79/102). Among 102 sputa specimens only 29 examined Mycobacterium tuberculosis by the traditional drug susceptibility test and 8 were rifaman-resistant strains. While using gene-chip, there were 20 among 102 sputa specimens identified as rifaman-resistance strains. Among total 55 rifaman-resistance strains detected by the gene-chips, the most frequent mutations were those associated with codon 531 (23 of 55; 41.8%), 526 (15 of 55; 27.27%) and 516 (9 of 55; 16.36%).
  
  
  CONCLUSIONS
  Results showed that this was a rapid, simple and highly specific method when using gene-chip to detect Mycobacterium tuberculosis and rifaman-resistant strains.
authors.affiliation: Medical Scientific Research Center, Guangxi Medical University, Nanning 530021, China.
authors.forename: Min
authors.initials: M
authors.lastname: He
authors.forename: Er-liang
authors.initials: EL
authors.lastname: Zeng
authors.forename: Yan-yan
authors.initials: YY
authors.lastname: Zheng
authors.forename: Zhuo
authors.initials: Z
authors.lastname: Tang
authors.forename: Xiang-chan
authors.initials: XC
authors.lastname: Lu
authors.forename: Bi-hui
authors.initials: BH
authors.lastname: Sun
authors.forename: Ding-kong
authors.initials: DK
authors.lastname: Xu
authors.forename: Zhi-yong
authors.initials: ZY
authors.lastname: Zhang
authors.forename: Li
authors.initials: L
authors.lastname: Yang
mesh_terms: D002681:China / Q000453:epidemiology; D004269:DNA, Bacterial / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D020411:Oligonucleotide Array Sequence Analysis; D015345:Oligonucleotide Probes; D017354:Point Mutation; D012293:Rifampin / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D013183:Sputum / Q000382:microbiology; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology / Q000382:microbiology*
chemical_list: D004269:DNA, Bacterial; D015345:Oligonucleotide Probes; D012293:Rifampin